# Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb)

> **NCT07418918** · PHASE2 · COMPLETED · sponsor: **Guangdong Longchuangji Pharmaceutical Co., Ltd.** · enrollment: 66 (actual)

## Conditions studied

- Bacterial Vaginosis

## Interventions

- **DRUG:** Vaginal Lactobacillus Dual Probiotic Capsules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07418918
- **Lead sponsor:** Guangdong Longchuangji Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-03
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-11-11
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07418918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07418918, "Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07418918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*